Wikidata

(Q36263988)

English

Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva) and gefitinib (Iressa).

scientific article

In more languages

Statements

title
Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva) and gefitinib (Iressa). (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16177282
retrieved
13 August 2017
author name string
Wandena S Siegel-Lakhai
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16177282
retrieved
13 August 2017
Jan H M Schellens
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
16177282
retrieved
13 August 2017
publication date
1 September 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
16177282
retrieved
13 August 2017
page(s)
579-589
1 reference
stated in
Europe PubMed Central
PubMed ID
16177282
retrieved
13 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q36263988&oldid=1519950657"